Bridgeway Capital Management, LLC Assembly Biosciences, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.8 - $1.74 $11,360 - $24,708	-14,200 Reduced 7.55%	174,000 $146,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $20.52 $24,140 - $291,384	14,200 Added 8.16%	188,200 $309,000
Q1 2022 May 16, 2022	BUY	$1.46 - $2.45 $215,642 - $361,865	147,700 Added 561.6%	174,000 $358,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $3.9 $118,378 - $147,030	-37,700 Reduced 58.91%	26,300 $92,000
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $326,800 - $392,159	-86,000 Reduced 57.33%	64,000 $248,000
Q1 2021 May 17, 2021	BUY	$4.33 - $6.63 $649,500 - $994,500	150,000 New	150,000 $690,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.